Selexagen Therapeutics, Inc. — Form D
Selexagen Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-12-09. The offering totals $497K, of which $497K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-12-09
- Form: D
- Accession: 0001507335-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $497K
- Amount sold: $497K
- Minimum investment: $1
- Investors: 4
- Date of first sale: 2010-11-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-151616
Issuer
- Name: Selexagen Therapeutics, Inc.
- CIK: 0001507335
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 4653 CARMEL MOUNTAIN ROAD, SAN DIEGO, CA, 92130
- Phone: (619) 252-4024
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Scott L Glenn | Director | Boulder, CO |
| Lauren G Otsuki | Director | San Diego, CA |
| Lauren G Otsuki | Executive Officer | San Diego, CA |
| Randall G Woods | Director | San Diego, CA |
| Patrick G O'Connor | Director | San Diego, CA |
| Patrick G O'Connor | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More